EUVIMEDEUVIMED entdecken
Crossref

Metformin-encapsulating immunoliposomes conjugated with anti-TROP 2 antibody fragments for the active targeting of triple-negative breast cancer

Daiva Vozgirdaite, Emilie Allard-Vannier, Florence Velge-Roussel, Emmanuel Douez, Louis Jolivet, Fanny Boursin, Igor Chourpa, Nicolas Aubrey, Katel Hervé-Aubert

Nanoscale · 2025

DOI: 10.1039/d4nr03224a ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanoscale, 2025. Verfasst von Daiva Vozgirdaite und 8 weiteren Autor:innen. Beteiligte Einrichtung: UPR 4301 CBM, CNRS, NMNS Department, University of Tours, 37200 Tours, France. katel.herve@univ-tours.fr. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Liposomes, Metformin, Single-Chain Antibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, Conseil Régional du Centre-Val de Loire.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study is focused on metformin-encapsulating liposome functionalization with single-chain variable fragments to increase the delivery and therapeutic efficacy for Trophoblast Cell-Surface Antigen 2 overexpressing triple-negative breast cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsLiposomesMetforminSingle-Chain AntibodiesAntigens, NeoplasmCell Adhesion MoleculesHumansCell Line, TumorFemaleImmunoconjugatesCell Proliferation

Substanzen

LiposomesMetforminSingle-Chain AntibodiesTACSTD2 protein, humanAntigens, NeoplasmCell Adhesion MoleculesImmunoconjugates

Autor:innen und Institutionen

  • UPR 4301 CBM, CNRS, NMNS Department, University of Tours, 37200 Tours, France. katel.herve@univ-tours.fr.
  • Pharmacy Department, University Hospital Center of Tours, 37200 Tours, France.
  • ISP UMR 1282, INRAE, BioMAP team, University of Tours, 37200 Tours, France.

Förderung

  • Agence Nationale de la Recherche
  • Conseil Régional du Centre-Val de Loire

Zitieren

APA

Vozgirdaite, D., Allard-Vannier, E., Velge-Roussel, F., Douez, E., Jolivet, L., Boursin, F., Chourpa, I., Aubrey, N., & Hervé-Aubert, K. (2025). Metformin-encapsulating immunoliposomes conjugated with anti-TROP 2 antibody fragments for the active targeting of triple-negative breast cancer. Nanoscale. https://doi.org/10.1039/d4nr03224a

Vancouver

Vozgirdaite D, Allard-Vannier E, Velge-Roussel F, Douez E, Jolivet L, Boursin F, et al. Metformin-encapsulating immunoliposomes conjugated with anti-TROP 2 antibody fragments for the active targeting of triple-negative breast cancer. Nanoscale. 2025. doi:10.1039/d4nr03224a

BibTeX
@article{Vozgirdaite2025,
  author = {Vozgirdaite, Daiva and Allard-Vannier, Emilie and Velge-Roussel, Florence and Douez, Emmanuel and Jolivet, Louis and Boursin, Fanny and Chourpa, Igor and Aubrey, Nicolas and Hervé-Aubert, Katel},
  title = {Metformin-encapsulating immunoliposomes conjugated with anti-TROP 2 antibody fragments for the active targeting of triple-negative breast cancer},
  journal = {Nanoscale},
  year = {2025},
  doi = {10.1039/d4nr03224a}
}
Kostenlos starten →